David Moher

David Moher

David Moher is a Canadian epidemiologist and research methodologist known for his influential work on systematic reviews, meta-analysis, and research reporting guidelines. He has played a central role in developing and promoting standards for the conduct and reporting of biomedical research, collaborating with international organizations, journals, and institutions. His career spans academic appointments, leadership of reporting initiatives, and contributions to evidence synthesis that have shaped guidelines across clinical medicine, public health, and health policy.

Early life and education

Moher grew up in Canada and pursued higher education that combined clinical, epidemiological, and methodological training. He received degrees from Canadian universities and completed graduate research that emphasized biostatistics and evidence synthesis. During his formative training he interacted with leading scholars and institutions that focus on clinical trials and systematic reviews, which influenced his later collaborations with international consortia and guideline developers.

Academic and research career

Moher has held academic appointments at major universities and research centers where he established programs in evidence synthesis, meta-research, and knowledge translation. He directed centers and units that coordinated systematic review methodology, clinical trial reporting, and meta-analysis training. His work connected with international research organizations, peer-reviewed journals, and governmental health agencies to improve research integrity and reproducibility. He authored and coauthored extensive literature across disciplines including clinical epidemiology, public health policy, and implementation science, collaborating with statisticians and trialists to advance methods for bias assessment, study selection, and data synthesis.

Contributions to research methodology and reporting

Moher is best known for co-developing and promoting influential reporting guidelines and tools that standardize how research is described and evaluated. He was a primary contributor to reporting statements that address randomized trials, systematic reviews, and observational studies, working with international panels comprised of journal editors, trialists, and methodologists. His methodological innovations include approaches to literature searching, risk-of-bias assessment, and meta-analytic techniques that inform evidence-based healthcare decisions. He advocated for transparency in trial registration and result reporting, partnering with organizations that oversee clinical trial registries and journal policies. Through collaborations with editorial groups and guideline developers, he helped integrate reporting checklists into peer review and publication workflows, influencing how investigators, clinicians, and policymakers interpret biomedical evidence.

Leadership and professional roles

Moher served in leadership roles at academic centers and international initiatives that promote methodological rigor and transparency in research. He led teams that provided training in systematic review conduct and reporting, coordinating efforts across universities, research hospitals, and professional societies. His collaborations extended to editorial boards of high-impact biomedical journals and to consortia that include regulatory bodies and funding agencies. He participated in workshops and conferences organized by prominent institutions to educate researchers about standards for trial conduct, evidence synthesis, and reporting practices. In these capacities he worked alongside leaders from clinical trial networks, health technology assessment agencies, and guideline panels to align methodological expectations across stakeholders.

Honors and awards

Moher has received recognitions from academic institutions and professional organizations for his contributions to research methodology and reporting. His awards reflect impact on clinical research practice, systematic review education, and improvements in research transparency adopted by journals and guideline developers. He has been invited to deliver keynote lectures and to chair international working groups that set standards for biomedical research dissemination.

Category:Canadian epidemiologists Category:Research methodologists Category:Medical researchers